Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients

被引：0

作者：

Agarwal, Kosh ^{[1
]}

Castells, Lluis ^{[2
]}

Mullhaupt, Beat ^{[3
]}

Rosenberg, William M. ^{[4
]}

McNabb, Brian L. ^{[5
]}

Arterburn, Sarah ^{[6
]}

Camus, Gregory ^{[7
]}

McNally, John ^{[5
]}

Brainard, Diana M. ^{[5
]}

Subramanian, Mani ^{[5
]}

Gonsalkorala, Enoka ^{[1
]}

Londono, Maria ^{[8
,9
]}

Dufour, Jean-Francois ^{[10
]}

Forns, Xavier ^{[8
,9
]}

机构：

[1] Kings Coll Hosp NHS Trust Fdn, London, England

[2] Hosp Univ Val dHebron, Barcelona, Spain

[3] Univ Hosp Zurich, Zurich, Switzerland

[4] UCL, Inst Liver & Digest Hlth, London, England

[5] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[6] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[7] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[8] Hosp Clin Barcelona, CIBEREHD, Barcelona, Spain

[9] IDIBAPS, Barcelona, Spain

[10] Univ Bern, Bern, Switzerland

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1069

引用

页码：571A / 571A

页数：1

共 50 条

[31] Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients [J].

Adenugba, Akinbami ;

Hornung, Matthias ;

Weigand, Kilian ;

Peschel, Georg ;

Junger, Henrik ;

Kupke, Paul ;

Lang, Hauke ;

Marquardt, Jens U. ;

Zimmermann, Tim ;

Geissler, Edward K. ;

Schlitt, Hans J. ;

Werner, Jens M. .

TRANSPLANTATION, 2021, 105 (10) :2226-2238

[32] EXPRESSION OF HEPATITIS C VIRUS (HCV) RECEPTORS IN GRAFTS FROM HCV-INFECTED LIVER TRANSPLANT RECIPIENTS [J].

Crespo, G. ;

Mensa, L. ;

Gastinger, M. ;

Miquel, R. ;

Perez del Pulgar, S. ;

Emerson, S. ;

Purcell, R. H. ;

Forns, X. .

JOURNAL OF HEPATOLOGY, 2010, 52 :S251-S251

[33] Regulatory and effector T-cell responses in HCV-infected liver transplant recipients [J].

Kaplan, David E. ;

Nakamoto, Nobuhiro ;

Ganesan, Sutharsan ;

Coleclough, Jennifer ;

Kaminski, Mary ;

Xin, Dong ;

Abraham, Shaked ;

Chang, Kyong-Mi .

HEPATOLOGY, 2006, 44 (04) :240A-240A

[34] Recent decrease in patient survival among HCV-infected liver transplant recipients. [J].

Martinez, F ;

Berenguer, M ;

Prieto, M ;

San Juan, F ;

Rayon, M ;

Mir, J ;

Berenguer, J .

HEPATOLOGY, 2001, 34 (04) :409A-409A

[35] Increased mortality following acute cellular rejection in HCV-infected liver transplant recipients [J].

Charlton, MR ;

Seaber, EC ;

Wiesner, RH ;

Everhart, J ;

Zetterman, R ;

Lake, JR ;

Hoofnagle, JH .

TRANSPLANTATION, 1999, 67 (07) :S16-S16

[36] HIGH EFFICACY OF SOFOSBUVIR/VELPATASVIR PLUS GS-9857 FOR 12 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1-6 HCV-INFECTED PATIENTS, INCLUDING THOSE PREVIOUSLY TREATED WITH DIRECT-ACTING ANTIVIRALS [J].

Lawitz, E. ;

Kowdley, K. ;

Curry, M. ;

Reau, N. ;

Nguyen, M. ;

Kwo, P. ;

Jacobson, I. ;

Tran, T. T. ;

Nahass, R. ;

Hinestrosa, F. ;

Herring, R., Jr. ;

Bennet, M. ;

Yang, J. C. ;

Stamm, L. M. ;

An, Di ;

Dvory-Sobol, H. ;

Brainard, D. M. ;

McHutchison, J. G. ;

Schiff, E. ;

Davis, M. ;

Etzkorn, K. ;

Chung, R. T. ;

Pound, D. ;

Rodriguez-Torres, M. ;

Reddy, K. R. ;

Younes, Z. ;

Gane, E. J. .

JOURNAL OF HEPATOLOGY, 2016, 64 :S139-S140

[37] A Randomized, Controlled, Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir/Velpatasvir for 12 Weeks in Direct Acting Antiviral-Experienced Patients with Genotype 1-6 HCV Infection: The POLARIS-4 Study [J].

Zeuzem, Stefan ;

Flamm, Steven L. ;

Tong, Myron J. ;

Vierling, John M. ;

Pianko, Stephen ;

Buggisch, Peter ;

de Ledinghen, Victor ;

Hyland, Robert H. ;

Wu, Xiaoru ;

Svarovskaia, Evguenia S. ;

Stamm, Luisa M. ;

Brainard, Diana M. ;

Subramanian, Mani ;

McHutchison, John G. ;

Verna, Elizabeth C. ;

Bansal, Meena B. ;

Landis, Charles S. ;

Strasser, Simone I. ;

Cooper, Curtis ;

Kowdley, Kris V. .

HEPATOLOGY, 2016, 64 :59A-59A

[38] A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis [J].

Ryan B. Perumpail ;

Robert J. Wong ;

Edward A. Pham ;

John P. Higgins ;

Tami J. Daugherty ;

Aijaz Ahmed .

Digestive Diseases and Sciences, 2016, 61 :39-41

[39] A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis [J].

Perumpail, Ryan B. ;

Wong, Robert J. ;

Pham, Edward A. ;

Higgins, John P. ;

Daugherty, Tami J. ;

Ahmed, Aijaz .

DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (01) :39-41

[40] High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals [J].

Lawitz, Erik ;

Kowdley, Kris ;

Curry, Michael ;

Reau, Nancy ;

Nguyen, Mindie ;

Kwo, Paul ;

Jacobson, Ira M. ;

Tran, Tram ;

Nahass, Ronald ;

Hinestrosa, Frederico ;

Herring, Robert ;

Bennett, Michael ;

Llewellyn, Joseph ;

Yang, Jenny ;

Stamm, Luisa ;

Brainard, Diana M. ;

McHutchison, John G. ;

Schiff, Eugene ;

Davis, Mitchell ;

Etzkorn, Kyle ;

Chung, Raymond ;

Pound, David ;

Rodriguez-Torres, Maribel ;

Reddy, K. Rajender ;

Gane, Edward .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S380-S380

← 1 2 3 4 5 →